|
|
|
Insider
Information: |
Schlesinger Sarah J. |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
142,206 |
|
Indirect Shares
|
15,600 |
|
|
Direct
Value |
$1,633,414 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
157,806 |
|
|
Total
Value |
$1,633,414 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ariad Pharmaceuticals Inc |
ARIA |
Director |
2016-02-01 |
37,500 |
2016-02-01 |
15,600 |
Premium* |
|
Innoviva Inc |
INVA |
Director |
2023-05-22 |
104,706 |
2018-02-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2014-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2014-08-12 |
4 |
AB |
$5.52 |
$7,176 |
I/I |
1,300 |
1,300 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2014-08-13 |
4 |
AB |
$5.71 |
$7,423 |
I/I |
1,300 |
2,600 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2014-09-09 |
4 |
AB |
$5.93 |
$7,709 |
I/I |
1,300 |
3,900 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2014-09-10 |
4 |
AB |
$5.75 |
$7,475 |
I/I |
1,300 |
5,200 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2014-10-14 |
4 |
AB |
$5.07 |
$6,591 |
I/I |
1,300 |
6,500 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2014-10-15 |
4 |
AB |
$5.03 |
$6,539 |
I/I |
1,300 |
7,800 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2014-11-11 |
4 |
AB |
$6.30 |
$8,190 |
I/I |
1,300 |
9,100 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2014-11-12 |
4 |
AB |
$6.22 |
$8,086 |
I/I |
1,300 |
10,400 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2014-12-16 |
4 |
AB |
$6.07 |
$7,891 |
I/I |
1,300 |
11,700 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2014-12-17 |
4 |
AB |
$6.11 |
$7,943 |
I/I |
1,300 |
13,000 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2015-01-13 |
4 |
AB |
$6.97 |
$9,061 |
I/I |
1,300 |
14,300 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2015-01-14 |
4 |
AB |
$6.25 |
$8,125 |
I/I |
1,300 |
15,600 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2015-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
25,000 |
0 |
- |
|
ARIA |
Ariad Pharmaceuticals Inc |
Director |
|
2016-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
37,500 |
0 |
- |
|
INVA |
Innoviva Inc |
Director |
|
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
10,517 |
10,517 |
0 |
- |
|
INVA |
Innoviva Inc |
Director |
|
2018-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
14,249 |
24,766 |
0 |
- |
|
INVA |
Innoviva Inc |
Director |
|
2019-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
16,399 |
41,165 |
0 |
- |
|
INVA |
Innoviva Inc |
Director |
|
2020-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
16,917 |
58,082 |
0 |
- |
|
INVA |
Innoviva Inc |
Director |
|
2021-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
17,482 |
75,564 |
0 |
- |
|
INVA |
Innoviva Inc |
Director |
|
2022-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
12,647 |
88,211 |
0 |
- |
|
INVA |
Innoviva Inc |
Director |
|
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
16,495 |
104,706 |
0 |
- |
|
22 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|